Centrosomes and myeloma; aneuploidy and proliferation

by Chng, W.J., Fonseca, R.
Published 2016

A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple Myeloma

by Chung, T.-H., Mulligan, G., Fonseca, R., Chng, W.J.
Published 2014

PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation

by Teoh P.J., Bi C., Sintosebastian C., Tay L.S., Fonseca R., Chng W.J.
Published 2020

The centrosome index is a powerful prognostic marker in myeloma and identifies a cohort of patients that might benefit from aurora kinase inhibition

by Chng, W.J., Braggio, E., Fonseca, R., Mulligan, G., Bryant, B., Remstein, E., Dogan, A., Valdez, R.
Published 2011

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma

by Bi, C, Chung, T.-H, Huang, G, Zhou, J, Yan, J, Ahmann, G.J, Fonseca, R, Chng, W.J
Published 2020

Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalities

by Jimenez-Zepeda, V.H., Chng, W.J., Schop, R.F.J., Braggio, E., Leis, J.F., Kay, N., Fonseca, R.
Published 2016

Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: Identification of 1p31-32 deletion as a prognostic factor in myeloma

by Chng, W.J., Van, Wier S., Keats, J.J., Bergsagel, P.L., Fonseca, R., Gertz, M.A., Chung, T.-H., Baker, A., Carpten, J.
Published 2011

Clinical and biological implications of MYC activation: A common difference between MGUS and newly diagnosed multiple myeloma

by Chng, W.-J., Huang, G.F., Chung, T.H., Ng, S.B., Gonzalez-Paz, N., Troska-Price, T., Mulligan, G., Chesi, M., Bergsagel, P.L., Fonseca, R.
Published 2014

IMWG consensus on risk stratification in multiple myeloma

by Chng, W.J., Dispenzieri, A., Chim, C.-S., Fonseca, R., Goldschmidt, H., Lentzsch, S., Munshi, N., Palumbo, A., Miguel, J.S., Sonneveld, P., Cavo, M., Usmani, S., Durie, B.G., Avet-Loiseau, H.
Published 2016

Clinical and biological significance of RAS mutations in multiple myeloma

by Chng, W.J., Van, Wier S., Fonseca, R., Gonzalez-Paz, N., Price-Troska, T., Rajkumar, S.V., Kyle, R.A., Henderson, K.J., Greipp, P., Jacobus, S., Oken, M.M., Van, Ness B.
Published 2011

Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities

by Braggio, E., Dogan, A., Keats, J.J., Chng, W.J., Huang, G., Matthews, J.M., Maurer, M.J., Law, M.E., Bosler, D.S., Barrett, M., Lossos, I.S., Witzig, T.E., Fonseca, R.
Published 2014